Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Volin

Showing results (21-30 of 131) with videos related to

Pageof 14
Sort By:
Blood|September 26, 2000
Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: a prospective randomized studyT Ruutu, L Volin, T Parkkali, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|December 1, 1992
Immunohistology of skin and rectum biopsies in bone marrow transplant recipientsR Leskinen, E Taskinen, L Volin, et al.
Bone Marrow Transplantation|January 1, 1991
Karyotype and BCR studies after bone marrow transplantation for chronic myeloid leukaemiaT Ruutu, P Peltomäki, L Volin, et al.
Journal of Internal Medicine|April 1, 1990
Cardiac involvement in bone marrow transplantation: serial changes in left ventricular size, mass and performanceM Kupari, L Volin, A Suokas, et al.
Bone Marrow Transplantation|May 1, 1996
Feasibility and toxicity of interferon maintenance therapy after allogeneic BMT for multiple myeloma: a pilot study of the EBMTD Samson, L Volin, U Schanz, et al.
Leukemia|October 29, 2004
Allogeneic stem cell transplantation reverses the poor prognosis of CML patients with deletions in derivative chromosome 9T Lundán, L Volin, T Ruutu, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 27, 2006
Serum osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) concentrations in allogeneic stem cell transplant-recipients: a role in bone loss?K Kananen, L Volin, K Laitinen, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 14, 2011
Low incidence of invasive aspergillosis in allogeneic stem cell transplant recipients receiving amphotericin B inhalation prophylaxisA Nihtinen, V-J Anttila, T Ruutu, et al.
Blood|May 1, 1997
Prognostic value of metaphase-fluorescence in situ hybridization in follow-up of patients with acute myeloid leukemia in remissionW El-Rifai, T Ruutu, E Elonen, et al.
Annals of Internal Medicine|June 15, 1990
Cytomegalovirus is frequently isolated in bronchoalveolar lavage fluid of bone marrow transplant recipients without pneumoniaP Ruutu, T Ruutu, L Volin, et al.
Pageof 14

Showing results (21-30 of 131) with videos related to

Sort By:
Pageof 14
Blood|September 26, 2000
Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: a prospective randomized studyT Ruutu, L Volin, T Parkkali, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|December 1, 1992
Immunohistology of skin and rectum biopsies in bone marrow transplant recipientsR Leskinen, E Taskinen, L Volin, et al.
Bone Marrow Transplantation|January 1, 1991
Karyotype and BCR studies after bone marrow transplantation for chronic myeloid leukaemiaT Ruutu, P Peltomäki, L Volin, et al.
Journal of Internal Medicine|April 1, 1990
Cardiac involvement in bone marrow transplantation: serial changes in left ventricular size, mass and performanceM Kupari, L Volin, A Suokas, et al.
Bone Marrow Transplantation|May 1, 1996
Feasibility and toxicity of interferon maintenance therapy after allogeneic BMT for multiple myeloma: a pilot study of the EBMTD Samson, L Volin, U Schanz, et al.
Leukemia|October 29, 2004
Allogeneic stem cell transplantation reverses the poor prognosis of CML patients with deletions in derivative chromosome 9T Lundán, L Volin, T Ruutu, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 27, 2006
Serum osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) concentrations in allogeneic stem cell transplant-recipients: a role in bone loss?K Kananen, L Volin, K Laitinen, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 14, 2011
Low incidence of invasive aspergillosis in allogeneic stem cell transplant recipients receiving amphotericin B inhalation prophylaxisA Nihtinen, V-J Anttila, T Ruutu, et al.
Blood|May 1, 1997
Prognostic value of metaphase-fluorescence in situ hybridization in follow-up of patients with acute myeloid leukemia in remissionW El-Rifai, T Ruutu, E Elonen, et al.
Annals of Internal Medicine|June 15, 1990
Cytomegalovirus is frequently isolated in bronchoalveolar lavage fluid of bone marrow transplant recipients without pneumoniaP Ruutu, T Ruutu, L Volin, et al.
Pageof 14